Zhan, Lijuan <br/><br/>
Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.  [electronic resource] 

 -  Free radical biology & medicine  Aug 2012 
 - 758-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4596 
<br/><br/><label>Standard No.: </label>10.1016/j.freeradbiomed.2012.05.041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antioxidant Response Elements<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Differentiation<br/>Cell Line, Tumor--drug effects<br/>Cell Survival--drug effects<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Etoposide--pharmacology<br/>Gene Expression Regulation--drug effects<br/>Gene Knockdown Techniques<br/>Glutamate-Cysteine Ligase--genetics<br/>Heme Oxygenase-1--genetics<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Kelch-Like ECH-Associated Protein 1<br/>Lung Neoplasms--drug therapy<br/>Models, Biological<br/>NAD(P)H Dehydrogenase (Quinone)--genetics<br/>NF-E2-Related Factor 2--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Oxides--pharmacology<br/>PPAR gamma--agonists<br/>Proto-Oncogene Mas<br/>RNA Interference<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology